Stock Rating Upgrade
Reflecting improving fundamentals and high Appreciation Potential, the Value Trend Rating for Biogen Inc (NASDAQ: BIIB) improved during the last several trading days. BIIB’s current Value Trend Rating is C and the prior Rating was D. Details supporting this higher rating are included in our next report.
Recent Price Action
Biogen Inc (NASDAQ: BIIB) stock closed at $202.00 on 8/9/24 after a modest decline of -1.0%. However, unusually low trading volume at 54% of normal accompanied the decline. The stock has declined -4.1% during the last week and has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be above the cost of capital, BIIB is expected to continue to be a major Value Builder.
Biogen has a current Value Trend Rating of C (Low Neutral). This VT Rating improved in recent days from D previously. The Value Trend Rating reflects inconsistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Biogen has a neutral Appreciation Score of 58 but a poor Power Rating of 29, resulting in the Low Neutral Value Trend Rating.
Be the first to comment